Figure 1 | Scientific Reports

Figure 1

From: Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy

Figure 1

GRh2 dose-dependently inhibits HCC cell growth.

We gave GRh2 at different doses (0.01 mg/ml, 0.1 mg/ml and 1 mg/ml) to the cultured HCC cells. (A,B) GRh2 dose-dependently decreased the cell viability of HepG2 cells in either a CCK-8 assay (A), or a MTT assay (B). (C,D) GRh2 dose-dependently decreased the cell viability of Huh7 cells in either a CCK-8 assay (C), or a MTT assay (D). *p < 0.05.

Back to article page